全文获取类型
收费全文 | 48051篇 |
免费 | 4590篇 |
国内免费 | 1351篇 |
专业分类
耳鼻咽喉 | 629篇 |
儿科学 | 827篇 |
妇产科学 | 642篇 |
基础医学 | 4328篇 |
口腔科学 | 492篇 |
临床医学 | 3513篇 |
内科学 | 3140篇 |
皮肤病学 | 5826篇 |
神经病学 | 1609篇 |
特种医学 | 1858篇 |
外国民族医学 | 12篇 |
外科学 | 4249篇 |
综合类 | 5446篇 |
预防医学 | 2738篇 |
眼科学 | 605篇 |
药学 | 7731篇 |
25篇 | |
中国医学 | 2182篇 |
肿瘤学 | 8140篇 |
出版年
2024年 | 46篇 |
2023年 | 772篇 |
2022年 | 862篇 |
2021年 | 1487篇 |
2020年 | 1723篇 |
2019年 | 1747篇 |
2018年 | 1727篇 |
2017年 | 1766篇 |
2016年 | 1947篇 |
2015年 | 1710篇 |
2014年 | 2856篇 |
2013年 | 3833篇 |
2012年 | 2762篇 |
2011年 | 3000篇 |
2010年 | 2433篇 |
2009年 | 2465篇 |
2008年 | 2366篇 |
2007年 | 2454篇 |
2006年 | 2200篇 |
2005年 | 1858篇 |
2004年 | 1609篇 |
2003年 | 1472篇 |
2002年 | 1253篇 |
2001年 | 1125篇 |
2000年 | 891篇 |
1999年 | 811篇 |
1998年 | 656篇 |
1997年 | 641篇 |
1996年 | 568篇 |
1995年 | 528篇 |
1994年 | 446篇 |
1993年 | 373篇 |
1992年 | 366篇 |
1991年 | 282篇 |
1990年 | 292篇 |
1989年 | 270篇 |
1988年 | 257篇 |
1987年 | 226篇 |
1986年 | 195篇 |
1985年 | 273篇 |
1984年 | 240篇 |
1983年 | 192篇 |
1982年 | 200篇 |
1981年 | 152篇 |
1980年 | 154篇 |
1979年 | 140篇 |
1978年 | 67篇 |
1977年 | 66篇 |
1976年 | 82篇 |
1975年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Cancer radiothérapie》2022,26(3):502-516
The aim of the review was to present the current literature status about replanning regarding anatomical and dosimetric changes in the target and OARs in the head and neck region during radiotherapy, to discuss and to analyze factors influencing the decision for adaptive radiotherapy of head and neck cancer patients. Significant progress has been made in head and neck patients’ evaluation and qualification for adapted radiotherapy over the past ten years. Many factors leading to anatomical and dosimetric changes during treatment have been identified. Based on the literature, the most common factors triggering re-plan are weight loss, tumor and nodal changes, and parotid glands shrinkage. The fluctuations in dose distribution in the clinical area are significant predictive factors for patients’ quality of life and the possibility of recovery. It has been shown that re-planning influence clinical outcomes: local control, disease free survival and overall survival. Regarding literature studies, it seems that adaptive radiotherapy would be the most beneficial for tumors of immense volume or those in the nearest proximity of the OARs. All researchers agree that the timing of re-planning is a crucial challenge, and there are still no clear consensus guidelines for time or criteria of re-planning. Nowadays, thanks to significant technological progress, the decision is mostly made based on observation and supported with IGRT verification. Although further research is still needed, adaptive strategies are evolving and now became the state of the art of modern radiotherapy. 相似文献
4.
《Cancer radiothérapie》2022,26(8):1034-1044
PurposeAssess the feasibility of a randomized controlled trial (RCT) exploring the use of medical imaging as a therapeutic education (TPE) intervention in external radiation therapy.Materials and methodsExperimental feasibility trial of “RCT” type carried out in a single-center, between November 2019 and March 2020, following adult patients treated by thoracic radiotherapy. In addition to the information usually given, the experimental group benefited from an intervention consisting in the visualization of their own medical images using the open-source software “Stone of Orthanc”.ResultsForty-nine patients were recruited with a refusal rate of 8.16% (4/49). 20 patients were withdrawn from the study for health reasons (COVID), 10 for medical reasons. All the remaining 15 participants completed the process. Although not significant, the experimental group showed a median gain in the perception of knowledge compared to the control group (+ 1.9 (1.6 – 2.2)) vs (+ 1.4 (1.4 – 1.8)), as well as a decrease in scores related to anxiety (? 3.0 (?4.5 - (?2.0)) vs ? 1.0 (?5.0 - 0.0)) and emotional distress ((? 5.0 (? 7.5 - (? 3.5)) vs (? 2.0 (? 5.0 - (? 1.0)) A significant reduction (p = 0.043) is observed for the depression score ((? 2.0 (?3.0 - (?1.5)) vs (0.0 (0.0 – 0.0)).ConclusionThis study demonstrates the feasibility of the project, with promising preliminary results. Some adaptations in order to conduct a larger-scale RCT are highlighted. 相似文献
5.
Preliminary study on blood coagulation and hemostatic effect and acute toxicity of Oxalis corniculata L. ethanol extract 下载免费PDF全文
In the present study, we aimed to observe the effects of ethanol extract of Oxalis corniculata L. on bleeding time (BT) and coagulation time (CT) and determine its acute toxicity in mice. Firstly, the ethanol extract of O. corniculata was administered to 40 mice, which were randomly divided into the normal control group, Yunnan Baiyao control group, low-dose group, and high-dose group. The low-dose (0.6 g/kg) and high-dose (1.2 g/kg) groups received ethanol extract of O. corniculata by gavage, and the BT and CT of the mice were measured by the slide method and tail clipping method, respectively. Secondly, the median lethal dose method was used with 50 mice to observe the physiological state, poisoning reaction, and death of the mice after intragastric administration. Finally, on the 14th day of the experiment, a necropsy was performed to observe any abnormality of the organs. In conclusion, in the coagulation and hemostasis tests, there were no statistical differences between the groups (P > 0.05), while there was a significant dose-response relationship, and the BT and CT were significantly shorter than those of the negative control group, which were comparable to the Yunnan Baiyao control group. Moreover, in the acute toxicity test, the median lethal dose of ethanol extract of O. corniculata was 6.0291 g/kg, with a 95% confidence interval of 5.3065–6.7829 mg/kg. 相似文献
6.
7.
王熙 《世界科学技术-中医药现代化》2022,24(11):187-193
化疗所致周围神经病变(Chemotherapy-induced peripheral neuropathy,CIPN)是临床常见的由化疗药物引起的一系列神经毒性症状,易造成神经功能障碍,四肢感觉弱化、缺失等,严重影响肿瘤患者生活质量及临床疗效。CIPN的发病机制尚不十分明确,目前也没有可广泛用于临床的特效药物治疗。中医药治疗CIPN具有特定的优势,取得了一定成绩,但在理论依据和临床疗效方面仍有一定的局限性。本文通过分析CIPN的临床症状特点,深入剖析其与中医肝阳虚理论之间的关系,探讨CIPN的中医病因病机与用药规律,指导临床治疗CIPN,以期更好地发挥中医药在肿瘤治疗中的减毒增效作用。 相似文献
8.
《Zeitschrift für medizinische Physik》2022,32(4):392-402
The aim of this study is to investigate the feasibility of manufacturing thin real-time relative dosimeters for clinical radiotherapy (RT) with potential applications for transmission monitoring in vivo dosimetry and pre-treatment dose verifications. Thin (≈1 μm) layers of a high sensitivity, wide bandgap semiconductor, the inorganic perovskite CsPbCl3, have been grown for the first time by magnetron sputtering on plastic substrates equipped with electrode arrays. Prototype devices have been tested in real-time configuration to evaluate the dose delivered by a 6 MV photon beam from a linear accelerator. Linearity of the charge with the dose has been verified over three order of magnitudes, linearity of the current signal with the dose rate has been also successfully tested in the range 0.5-4.3 Gy/min. The combination of high sensitivity per unit volume and wide bandgap provides high signal-to-noise ratios, up to 70, even at moderate applied voltages. The Schottky diode configuration allows the detector to operate without bias voltage (null bias).The blocking-barrier structure allows to confine the active volume within sub-millimetric sizes, a quite attractive feature in view to increase granularity and achieve the high spatial resolutions required in modern RT techniques. All the above-mentioned features indeed pave the way to a novel generation of flexible, transmission, real time dosimeters for clinical radiotherapy. 相似文献
9.
《Clinical genitourinary cancer》2022,20(5):442-451
IntroductionSelective internal radiation therapy (SIRT) is a potential treatment of primary renal cell carcinoma (RCC) deemed unsuitable for conventional therapy. RESIRT is the first-in-human study to evaluate safety and feasibility of SIRT for primary RCC.Patients and MethodsPatients with RCC, unsuitable for, or who declined conventional therapy, were eligible. A single transfemoral micro-catheter administration of yttrium-90 (Y-90) resin microspheres (SIR-Spheres) was delivered super selectively via the renal artery to the tumour at intended radiation doses of 75, 100, 150, 200, 300 Gy and a final cohort with a procedural endpoint of “imminent stasis,” in a dose-escalation design. Post-SIRT follow-up was 12 months. Study endpoints included safety and toxicity 30-days and 12-months post-SIRT and tumour response (RECIST v1.1).ResultsIn total, 21 patients were enrolled, mean (SD) age was 75 (9.3) years, WHO performance status was 0 in 81%, 12 (57%) had stage 3 chronic kidney disease, and 7 (33%) had prior contralateral nephrectomy. Overall, 71% of patients completed 12 months of follow-up. Intended doses were delivered without any dose-limiting toxicity. Seventeen out of 21 (81%) patients experienced an adverse event (AE) from any cause within 30 days post-SIRT; all SIRT-related AEs were grade 1 to 2. Best overall tumour responses were partial response 1/21 (4.8%), stable disease 19/21 (90.5%) and progressive disease 1/21 (4.8%).ConclusionThis study demonstrated good tolerability of SIRT at all dose levels including “imminent stasis” in treating primary tumours in RCC patients otherwise unsuitable for conventional therapy. SIRT with Y-90 resin microspheres may be a feasible treatment option for RCC. 相似文献
10.